Moxifloxacin Tablet Suppliers & Bulk Manufacturers
Available Forms: Tablets
Available Strengths: 400 mg
Reference Brands: Avelox (USA/EU/UK), Actira(EU), Avalox(EU)
Category:
Antibiotics
Moxifloxacin is used to treat certain infections caused by bacteria such as pneumonia, and skin, and abdominal (stomach area) infections. Moxifloxacin is also used to prevent and treat plague (a serious infection that may be spread on purpose as part of a bioterror attack.
Moxifloxacin Tablet is available in Tablets
and strengths such as 400 mg.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Moxifloxacin Tablet is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Moxifloxacin Tablet can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Moxifloxacin is a broad-spectrum fluoroquinolone antibiotic widely used for the treatment of various bacterial infections. It was approved by the U.S. Food and Drug Administration in 1999 and has since become an important option in modern antimicrobial therapy. Moxifloxacin works by inhibiting bacterial enzymes DNA gyrase and topoisomerase IV, which are essential for bacterial DNA replication, transcription, and repair. By blocking these enzymes, the drug effectively stops bacterial growth and helps eliminate infection.
Moxifloxacin is commonly prescribed for respiratory tract infections, including community-acquired pneumonia, acute exacerbations of chronic bronchitis, and acute bacterial sinusitis. It is also used in the treatment of skin and soft tissue infections, intra-abdominal infections, and certain complicated bacterial infections caused by susceptible microorganisms such as Streptococcus pneumoniae and Mycoplasma pneumoniae.
The drug is available in multiple dosage forms, including tablets, intravenous injections, and ophthalmic drops, allowing flexibility in treatment depending on the severity and type of infection. Due to its strong antibacterial activity and convenient once-daily dosing, moxifloxacin is widely used in hospital and outpatient settings. Proper medical supervision is recommended to ensure safe and effective use while minimizing the risk of antibiotic resistance.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing